Vital Signs - Medical Imaging in the Era of Personalized Medicine: An Overview of Key Clinical Molecular Imaging Modalities and Their Role in the Future of Medicine

 

Regular Price: USD 1,500

Special Price USD 1,050

30% OFF

* Required Fields

Regular Price: USD 1,500

Special Price USD 1,050

PAY BY INVOICE

Be the first to review this product

This issue of Vital Signs, released on June 13, 2011, provides a strategic insight on the personalized medicine market in medical imaging.
Additionally, a company spotlight is provided for TechniScan Medical Systems, a publicly traded medical device company that has developed a non-invasive imaging system that provides automated ultrasound images of the human breast. Reimbursement and regulatory news from the FDA is also provided for week of May 23, 2011.

Table of Contents

Vital Signs - Medical Imaging in the Era of Personalized Medicine: An Overview of Key Clinical Molecular Imaging Modalities and Their Role in the Future of MedicineVital Signs: 13 June 2011This week's issue




Related Research

Release Date : 19-Sep-17

Region : North America

Release Date : 08-Sep-17

Region : North America

Release Date : 22-Aug-17

Region : North America

Release Date : 08-Aug-17

Region : North America

Release Date : 31-Jul-17

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.